XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Summary of Stock Option Activity and Weighted Average Exercise Prices
The following table summarizes the Company’s stock option activity and weighted-average exercise prices:
Number Of
Options
Outstanding		Weighted-
Average
Exercise Price		Weighted-
Average
Remaining
Contractual
Life (in Years)		Aggregate
Intrinsic Value
(in thousands)
Balance outstanding—December 31, 202121,372,561 $3.31 5.5$3,735,819 
Options granted— — 
Options exercised(1,673,753)3.83 
Options forfeited or expired(101,980)5.94 
Balance outstanding—June 30, 202219,596,828 $3.26 4.9$1,802,576 
Ending Exercisable—June 30, 202216,977,114 $2.37 4.6$1,576,610 
Summary of Activity for Unvested RSUs
The following table summarizes the activity for the Company’s unvested RSUs and PSUs:
SharesWeighted-
Average Grant Date
Fair Value
Balance—December 31, 20218,081,269 $101.21 
Awarded3,119,713 124.03 
Vested(1,039,058)74.93 
Forfeited/canceled(422,308)103.66 
Unvested and outstanding—June 30, 20229,739,616 $111.22 
Summary of Activity for Unvested PSUs
The following table summarizes the activity for the Company’s unvested RSUs and PSUs:
SharesWeighted-
Average Grant Date
Fair Value
Balance—December 31, 20218,081,269 $101.21 
Awarded3,119,713 124.03 
Vested(1,039,058)74.93 
Forfeited/canceled(422,308)103.66 
Unvested and outstanding—June 30, 20229,739,616 $111.22 
Summary of Stock-based Compensation Expense
Stock-based compensation expense was included in the condensed consolidated statement of operations as follows (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2022202120222021
Cost of revenue$2,355 $829 $4,008 $1,530 
Research and development53,309 21,639 98,005 37,708 
Sales and marketing17,590 6,606 32,185 13,616 
General and administrative9,145 5,441 15,085 10,522 
Stock-based compensation, net of amounts capitalized82,399 34,515 149,283 63,376 
Capitalized stock-based compensation expense3,334 2,059 6,840 4,212 
Total stock-based compensation expense$85,733 $36,574 $156,123 $67,588